Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Aug 05, 2021 1:15pm
191 Views
Post# 33655399

RE:RE:RE:RE:RE:RE:RE:RE:What's the next level?

RE:RE:RE:RE:RE:RE:RE:RE:What's the next level?Yes, I am done with performance packages "just because" and agree, the share price will be the ultimate indicator and to ensure that there is some level of sustainable price range would be important. Sustainable rises are a reflection of both the quality of the agreements and forward discounted earnings/revenue predictions. In my view, because of the size of their existing war chest of shares accumulated over the years of empty promises, they should get a bonus after one year of sustainable prices over $1 per share.

As we move out of August and the deadness of summer, and the clarity comes to light on the previous mentioned milestones then I think that these low prices will quickly disappear. So enjoy it while we can if anyone is intrigued by the forward roster in the pipeline. 
<< Previous
Bullboard Posts
Next >>